Registration Frequencies

Weekly updated frequencies of observation starts at registration by medication are shown.
 
Fig 1) Patient numbers by biologic treatment at inclusion
Last update: | total n=
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: | total n=
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 1074 1371
Bimekizumab 342 0
Brodalumab 579

0
Certolizumab 226 0
Efalizumab 35 0
Etanercept 312 72
Golimumab 25 0
Guselkumab 1770 0
Infliximab 103 1
Ixekizumab 992 0
Risankizumab 1693 0
Secukinumab 2070 0
Tildrakizumab 1514 0
Ustekinumab 778 0
Apremilast 752 0
Ciclosporin 402 0
Fumaderm® 2694 0
Skilarence® 3286 0
Methotrexat 3922 0
Tofacitinib 2 0
Upadacitinib 5 0
Deucravacitinib 155 0
other systemics 356 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: | total n=
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: | total n=
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: | n= | updated monthly
Fig. 5) Registered PsoBest centers